Get the Daily Brief
Latest Biotech News
Human Embryo Implantation Captured in 3D and Real Time
Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital have achieved the first real-time, three-dimensional recording of human embryo implantation on synthetic...
Innovations in Cancer Immunotherapy and Biomarkers
Emerging studies are advancing precision oncology and immunotherapy through novel biomarker discoveries and drug development. A Fudan University-led study introduced a blood test predicting...
Advances in Neonatal and Pediatric Therapies
Breakthrough clinical developments are emerging in neonatal and pediatric care. Airway Therapeutics announced an expanded multinational Phase III trial of zelpultide alfa, targeting...
Breakthroughs in Genetic and Epigenetic Research
Recent research breakthroughs deepen understanding of gene regulation and chromatin dynamics impacting various diseases. German scientists developed a buffer modification enabling CUT&Tag assays...
Biopharma Funding and Market Trends in 2025
The biopharma sector saw record-breaking deal values in the first seven months of 2025, totaling $164 billion in non-M&A deals, a 36% increase over 2024. However, 2025 witnessed a notable IPO...
Environmental and Structural Biotechnologies Progress
Innovative biotechnologies addressing environmental and structural challenges have advanced significantly. Studies reveal the seismic vulnerability of unreinforced masonry facades improved by...
Neuroscience and Mental Health Insights
Recent studies provide new perspectives on mental health and neurological disorders. Research links loneliness with depression in adolescent and young adult cancer survivors, highlighting...
Big Data, AI, and Computational Biology Transformations
Cutting-edge developments are reshaping biotech through AI and computational advances. Large language models are revolutionizing drug discovery, enhancing speed and accuracy in molecular design....
FDA greenlights gene therapy for respiratory papillomatosis: Precigen scores rapid full approval
The U.S. Food and Drug Administration granted a swift and full approval to Precigen Inc.'s gene therapy, Papzimeos (zopapogene imadenovec), targeting recurrent respiratory papillomatosis (RRP)....
Pfizer’s sickle cell candidate fails Phase 3 trial: Setback for Global Blood Therapeutics asset
Pfizer announced the failure of its Phase 3 trial for inclacumab, a sickle cell disease candidate acquired through its $5.4 billion deal for Global Blood Therapeutics. The investigational drug did...
Human embryo implantation captured live in 3D: Novel imaging reveals early developmental biomechanics
Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital achieved the first ever real-time three-dimensional imaging of human embryo implantation into a collagen...
T cell therapy reshapes immunotherapy: Treg cells enhance pro-inflammatory Th17 response via IL-2
New research led by Cheng, Nan, and Ji uncovers a paradoxical immunological mechanism wherein regulatory T cells (Tregs) boost the pro-inflammatory T helper 17 (Th17) cell population through an...
Nab-paclitaxel and cisplatin combo shows superiority over gemcitabine regimen in biliary tract cancer
A multicenter randomized phase II trial published in BMC Cancer revealed that nab-paclitaxel combined with cisplatin outperforms gemcitabine plus cisplatin as chemotherapy in patients with...
Cell therapy manufacturing scales up: Made Scientific's new GMP facility in Princeton boosts capacity
Made Scientific celebrated the opening of a new 60,000-square-foot GMP-compliant manufacturing facility and headquarters in Princeton, New Jersey, enhancing its capabilities in cell therapy...
Genomill Health advances targeted NGS sample prep with Bridge Capture for clinical oncology
Finnish biotech Genomill Health introduced Bridge Capture, a novel targeted next-generation sequencing sample preparation technique enabling simple, cost-effective, and automatable detection of...
AI accelerates RNA vaccine delivery design: MIT reveals breakthroughs in lipid nanoparticle optimization
Massachusetts Institute of Technology researchers employed artificial intelligence to revolutionize the design of lipid nanoparticles (LNPs), crucial delivery vehicles for RNA vaccines and...
Platelets assume novel roles beyond clotting: Emerging evidence of DNA surveillance and cancer detection
Recent scientific investigations have expanded the understanding of platelets, traditionally known for their role in blood clotting, revealing unexpected functions in DNA damage surveillance and...
Loneliness linked to depression in adolescent and young adult cancer survivors
A recent study published in BMC Cancer explores the psychological aftermath of cancer survivorship among adolescents and young adults (AYAs), highlighting loneliness as a significant contributor...
FDA Approves Precigen’s Gene Therapy for Rare Respiratory Disease
The U.S. FDA has granted full and expedited approval to Precigen Inc.’s gene therapy, Papzimeos (zopapogene imadenovec), targeting recurrent respiratory papillomatosis (RRP), a rare disease marked...
Pfizer’s Sickle Cell Drug Fails Phase 3 Trial
Pfizer’s sickle cell disease candidate, inclacumab, failed to meet primary endpoints in a pivotal Phase 3 clinical trial, signaling a setback for the company's portfolio in hematology. This...